BriaCell Therapeutics Corp.
BCTXW · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $39 | $45 |
| - Cash | $10 | $1 | $21 | $41 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$10 | -$1 | $18 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$27 | -$5 | -$27 | -$34 |
| % Margin | – | – | – | – |
| Net Income | -$26 | -$5 | -$20 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -62.6 | -42.99 | -1.74 | -1.73 |
| % Growth | -45.6% | -2,370.7% | -0.6% | – |
| Operating Cash Flow | -$28 | -$24 | -$24 | -$12 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$28 | -$25 | -$24 | -$12 |